bioAffinity Technologies Opens Test Validation Trial of CyPath® Lung
17. Juli 2018 14:40 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, July 17, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced it has commenced its test validation trial for CyPath® Lung, an...